Anthrogen
We're training the next generation of protein foundation models.
Anthrogen is a company in healthcare based in San Francisco, CA, USA.
Profile
Proteins power everything from the cells in your body to creating materials you rely on every day—but until now, we’ve been forced to discover their functions by trial and error. Designing a new therapeutic can take decades and billions of dollars, and even our best industrial catalysts work at a snail’s pace compared to their theoretical optimums.
Anthrogen is changing that. By training massive AI foundation models on protein sequences and structures, we’ve unlocked the ability to generate—on demand—completely novel molecular machines with atomic-level precision. Simply describe the function you need, and our platform imagines the peptide or protein that will deliver it.
We're building models to speed up billions of years of evolution into the span of an afternoon's worth of compute.
The result? New-to-nature therapies, ultra-efficient catalysts for sustainable manufacturing, and a whole new frontier of molecular innovation—designed as precisely as any cutting-edge aircraft or microchip.
Its activity falls under healthcare; the profile below is assembled from public directory data.
The company is recorded as being based in San Francisco, CA, USA.
It is recorded at the Summer 2024 stage.
Its team size is recorded as 6 employees.
Directory analysis
Anthrogen trains large AI foundation models on protein sequences and structures to generate novel proteins and peptides on demand, aiming to accelerate drug and material discovery. The startup operates out of San Francisco and targets applications ranging from therapeutics to industrial catalysts. It positions itself as a tool that can turn functional specifications into atomic‑level molecular designs.
Positioning: The company sits at the intersection of AI and protein engineering, targeting both therapeutic and industrial markets. As a very early‑stage, small team with no disclosed funding, it is still establishing its commercial viability.
Note: Anthrogen offers AI‑driven protein design to speed up innovation.
Auto-generated directory analysis from public data · updated 12 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 6 |
| Stage | Summer 2024 |
Website: anthrogen.com
Browse related
Create a free account